» Articles » PMID: 34155143

Addiction to Golgi-resident PI4P Synthesis in Chromosome 1q21.3-amplified Lung Adenocarcinoma Cells

Overview
Specialty Science
Date 2021 Jun 22
PMID 34155143
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A chromosome 1q21.3 region that is frequently amplified in diverse cancer types encodes phosphatidylinositol (PI)-4 kinase IIIβ (PI4KIIIβ), a key regulator of secretory vesicle biogenesis and trafficking. Chromosome 1q21.3-amplified lung adenocarcinoma (1q-LUAD) cells rely on PI4KIIIβ for Golgi-resident PI-4-phosphate (PI4P) synthesis, prosurvival effector protein secretion, and cell viability. Here, we show that 1q-LUAD cells subjected to prolonged PI4KIIIβ antagonist treatment acquire tolerance by activating an miR-218-5p-dependent competing endogenous RNA network that up-regulates PI4KIIα, which provides an alternative source of Golgi-resident PI4P that maintains prosurvival effector protein secretion and cell viability. These findings demonstrate an addiction to Golgi-resident PI4P synthesis in a genetically defined subset of cancers.

Citing Articles

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics.

Tan X, Xiao G, Banerjee P, Wang S, Kurie J J Clin Invest. 2024; 134(17).

PMID: 39225096 PMC: 11364386. DOI: 10.1172/JCI182652.


: a novel potential therapeutic target for lung cancer.

Baldavira C, Prieto T, Nagai M, Capelozzi V Transl Lung Cancer Res. 2024; 13(1):199-204.

PMID: 38404996 PMC: 10891409. DOI: 10.21037/tlcr-23-734.


Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma.

Zhang A, He X, Zhang C, Tang X BMC Med Genomics. 2024; 17(1):53.

PMID: 38365684 PMC: 10870608. DOI: 10.1186/s12920-024-01823-9.


Pulsatilla saponin D regulates ras-related C3 botulinum toxin substrate 3 (RAC3) to overcome resistance to paclitaxel in lung adenocarcinoma cells.

Lu Y, He W, Huang X, Xiao X BMC Cancer. 2024; 24(1):55.

PMID: 38200409 PMC: 10777557. DOI: 10.1186/s12885-024-11841-6.


Construction and validation of an efferocytosis-related prognostic signature in lung adenocarcinoma.

Liu J, Wei L J Cancer Res Clin Oncol. 2023; 149(16):14577-14596.

PMID: 37578523 DOI: 10.1007/s00432-023-05251-7.


References
1.
Tan X, Banerjee P, Pham E, Rutaganira F, Basu K, Bota-Rabassedas N . PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med. 2020; 12(527). PMC: 7702266. DOI: 10.1126/scitranslmed.aax3772. View

2.
Minogue S . The Many Roles of Type II Phosphatidylinositol 4-Kinases in Membrane Trafficking: New Tricks for Old Dogs. Bioessays. 2017; 40(2). DOI: 10.1002/bies.201700145. View

3.
Waugh M . Amplification of Chromosome 1q Genes Encoding the Phosphoinositide Signalling Enzymes PI4KB, AKT3, PIP5K1A and PI3KC2B in Breast Cancer. J Cancer. 2014; 5(9):790-6. PMC: 4216804. DOI: 10.7150/jca.9794. View

4.
Klempner S, Myers A, Cantley L . What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway. Cancer Discov. 2013; 3(12):1345-54. PMC: 3864542. DOI: 10.1158/2159-8290.CD-13-0063. View

5.
Robinson D, Wu Y, Vats P, Su F, Lonigro R, Cao X . Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet. 2013; 45(12):1446-51. PMC: 4009946. DOI: 10.1038/ng.2823. View